Starling Oncology, Inc.
STLN- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Starling Oncology, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 45 | +10 |
| Shares | 15.1M | 18.3K | 18.4M | +3.36M (+22.2%) |
| Value | $21.2M | $25.6K | $37.6M | +$16.5M (+77.9%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Starling Oncology, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cincinnati Insurance Co | 699,500 | $1.43M | 0.03% |
| Element Pointe Advisors, LLC | 398,052 | $812.0K | 0.23% |
| Squarepoint Ops LLC | 96,862 | $197.6K | 0.00% |
| Fielder Capital Group LLC | 70,192 | $143.2K | 0.09% |
| FreeGulliver LLC | 65,000 | $132.6K | 0.18% |
| Bank of New York Mellon Corp | 48,719 | $99.4K | 0.00% |
| Marshall Wace, LLP | 39,282 | $80.1K | 0.00% |
| Acadian Asset Management LLC | 38,639 | $78.0K | 0.00% |
| Jane Street Group, LLC | 28,187 | $57.5K | 0.00% |
| WealthShield Partners, LLC | 24,126 | $49.2K | 0.01% |
| Cubist Systematic Strategies, LLC | 12,320 | $25.1K | 0.00% |
| Tower Research Capital LLC (TRC) | 12,046 | $24.6K | 0.00% |
| Boston Financial Mangement LLC | 9,485 | – | – |
Sold out (3)
Institutions that held Starling Oncology, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Pinebridge Investments, L.P. | 29,779 | $41.7K |
| Virtu Financial LLC | 14,044 | $20.0K |
| Toronto Dominion Bank | 336 | $470 |
Not filed for Q4 2023 yet (1)
Institutions that held Starling Oncology, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| First Republic Investment Management, Inc. | 18,300 | $25.6K |